オンコリスバイオファーマ株式会社
1 known investors
Find your way into オンコリスバイオファーマ株式会社
Oncolys develops viral therapy drugs and treatments for cancer and severe viral infections, with a focus on oncolytic viruses and rare diseases. The company operates a hybrid business model combining licensing partnerships with pharmaceutical firms and direct commercialization of its own therapies.
Founders & leadership
浦
浦田泰生Representative Director and President
Investors · 1
Frequently asked questions
- What does オンコリスバイオファーマ株式会社 do?
- Oncolys develops viral therapy drugs and treatments for cancer and severe viral infections, with a focus on oncolytic viruses and rare diseases. The company operates a hybrid business model combining licensing partnerships with pharmaceutical firms and direct commercialization of its own therapies.
- Who founded オンコリスバイオファーマ株式会社?
- オンコリスバイオファーマ株式会社 was founded by 浦田泰生.
- Who are オンコリスバイオファーマ株式会社's investors?
- オンコリスバイオファーマ株式会社's investors include Nippon Venture Capital.